Docoh
Loading...

CDNA Caredx

News

Pro users get this 30m faster
CareDx And Eledon Pharmaceuticals Announce Collaborative Research Agreement
19 Oct 21
News, Contracts
CareDx, Inc. (NASDAQ:CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and
Cathie Wood's ARK Invest Posts Fund Purchases For Tuesday, Oct. 12 2021: TDOC, CRSP, NTLA, SSYS, MKFG, BLDE, VLD, GENI, TWOU, CDNA, ARCT, SLGC, BEAM, QSI, DYNS
13 Oct 21
Hedge Funds, Trading Ideas, General
Teladoc Health (TDOC) - 198,681 Shares CRISPR Therapeutics (CRSP) - 61,732 Intellia Therapeutics (NTLA) - 13,254 Stratasys (SSYS) - 26,989 Markforged (MKFG) - 179,691 Blade Air Mobility (BLDE) - 94,782 Velo3D
Cathie Wood's ARK Invest Posts Fund Purchases For Monday, Oct. 11, 2021: TDOC, CRSP, NTLA, NIU, BLDE, MKFG, VLD, TWOU, GENI, BEAM, SLGC, CDNA, QSI, ACHR
12 Oct 21
Hedge Funds, Trading Ideas, General
Teladoc Health (TDOC) - 211,626 CRISPR Therapeutics (CRSP) - 248,148 Intellia Therapeutics (NTLA) - 37,991 Niu Technologies (NIU) - 159,329 Blade Air Mobility (BLDE)
CareDx Says AlloSure Launches For Lung Transplant Patients
12 Oct 21
News, FDA
CareDx, Inc. (NASDAQ:CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and
CareDx Presents Latest Data On AlloSeq Portfolio At ASHI 2021
27 Sep 21
News
CareDx, Inc. (NASDAQ:CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and
Cathie Wood's ARK Invest Posts Fund Sales For Friday, Aug. 20, 2021: PRLB, SQ, SE, XONE, BIDU, MELI, PTSI, CDNA
23 Aug 21
Hedge Funds, Trading Ideas, General
Proto Labs (PRLB) - 17,225 Square (SQ) - 79,325 Sea (SE) - 66,115 The ExOne Co (XONE) - 91,224 Baidu (BIDU) - 84,975 MercadoLibre (MELI) - 5,185 Pluristem
Miromatrix Medical Reports Strategic Investors Were Involved In Series C Financing Following IPO: Baxter, CareDx, DaVita; No Size Of Investment Disclosed
11 Aug 21
News
Miromatrix Medical Inc. (NASDAQ:MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save patients' lives and improve quality of life around the world,
CareDx Raises FY21 Sales Guidance From $270M-$280M To $280M-$290M vs $278.39M Est.
29 Jul 21
News, Guidance
For the full year 2021, CareDx now expects revenue to be in the range of $280 million to $290 million (previously $270 million to $280 million).
CareDx Q2 Adj. EPS $0.11 Beats $0.02 Estimate, Sales $74.19M Beat $67.55M Estimate
29 Jul 21
Earnings, News
CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.02 by 450 percent. This is a 175 percent increase over earnings of $0.04 per share from the same period
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
29 Jul 21
Biotech, Earnings, News, Penny Stocks, Guidance, Small Cap, FDA, IPOs, General
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28)
Earnings Scheduled For July 29, 2021
29 Jul 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter.
The Week Ahead In Biotech: Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
25 Jul 21
Biotech, Earnings, News, Penny Stocks, Previews, Small Cap, FDA, IPOs, Top Stories, Trading Ideas
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start to the pharma reporting season.

Press releases

Pro users get this 30m faster
CareDx to Report Third Quarter 2021 Financial Results
14 Oct 21
News, Press Releases
SOUTH SAN FRANCISCO, Calif., Oct. 14, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated,
AlloSure, the First dd-cfDNA in Heart and Kidney Transplantation, Launches for Lung Transplant Patients
12 Oct 21
News, Press Releases, General
SOUTH SAN FRANCISCO, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated,
CareDx Extends Leadership in Multimodality Transplant Care with KidneyCare Validation Publication
30 Sep 21
Health Care, Press Releases, General
SOUTH SAN FRANCISCO, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA) – a leading precision medicine company focused on the discovery, development, and commercialization of clinically
CareDx Continues to Fight for Innovation in Transplantation
28 Sep 21
News, Legal, Press Releases
False Advertising Lawsuit Against Natera is Set to Go to Trial CareDx Plans to Appeal Recent Ruling in Patent Case SOUTH SAN FRANCISCO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a leading
CareDx to Participate in Upcoming Conferences
2 Sep 21
News, Press Releases
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically
CareDx Showcases Leadership in Global Transplantation at ESOT 2021
26 Aug 21
News, Health Care, Press Releases
SOUTH SAN FRANCISCO, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated,
Miromatrix Announces Key Strategic Investors to Advance the Development of Bioengineered Livers and Kidneys
11 Aug 21
News, Financing, Press Releases
EDEN PRAIRIE, Minn., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ:MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save
CareDx Reports 77% Revenue Growth for Second Quarter of 2021 and Increases Full Year Revenue Guidance
29 Jul 21
Earnings, Press Releases
SOUTH SAN FRANCISCO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated,